Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP330508.RAqm8c0azza_x4GFEf9q-6TgPCRpiilLx_NUifBQYX1yM130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330508.RAqm8c0azza_x4GFEf9q-6TgPCRpiilLx_NUifBQYX1yM130_provenance.
• NP311736.RAX126WsiQtdvM0Ti8C1BRATEU_WOBVtCseU5Rt8lFn3M130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP311736.RAX126WsiQtdvM0Ti8C1BRATEU_WOBVtCseU5Rt8lFn3M130_provenance.
• NP575243.RA9bm54dG4cKLjc0gJOUJZCAcarPor3HJd3LLZte4N1X8130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP575243.RA9bm54dG4cKLjc0gJOUJZCAcarPor3HJd3LLZte4N1X8130_provenance.
• NP843100.RATZzALa5k9C0TkHMCYPbG02d9_lFesbjtvY9poNOxfxo130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843100.RATZzALa5k9C0TkHMCYPbG02d9_lFesbjtvY9poNOxfxo130_provenance.
• NP881510.RARk9mbbEfT-q2mVzwhMqQJE9oNQahH4LYLdixvenJ9UE130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881510.RARk9mbbEfT-q2mVzwhMqQJE9oNQahH4LYLdixvenJ9UE130_provenance.
• assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP368668.RAe7Vzwt9_yzYqBqIWoObMxN5dkNUpPS2Bd4u6lvqgV2Y130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368668.RAe7Vzwt9_yzYqBqIWoObMxN5dkNUpPS2Bd4u6lvqgV2Y130_provenance.
• NP612339.RAWGU-W2V066kOAjwvBWpE_UbK6oNiJBgRDikXUmHOW3s130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP612339.RAWGU-W2V066kOAjwvBWpE_UbK6oNiJBgRDikXUmHOW3s130_provenance.
• NP532461.RAEHWbyctkkL4EQWi5JzCFd88NmZhYDUOlnQXAudaRqFk130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP532461.RAEHWbyctkkL4EQWi5JzCFd88NmZhYDUOlnQXAudaRqFk130_provenance.
• assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP370377.RACIsQ3wxGWCAZqJVDW1hgqheaJ1bZxJ1AF8OchuMvj9E130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370377.RACIsQ3wxGWCAZqJVDW1hgqheaJ1bZxJ1AF8OchuMvj9E130_provenance.
• NP584029.RAB0u-lVRBDKUdYGYoPticZ9jqJqRi3y_tJ1GJmswNwBE130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584029.RAB0u-lVRBDKUdYGYoPticZ9jqJqRi3y_tJ1GJmswNwBE130_provenance.
• NP584028.RAc8kLnGjRmqsaBMRF5TTakw6xEV7uLgCQYDsbuuPOyXI130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584028.RAc8kLnGjRmqsaBMRF5TTakw6xEV7uLgCQYDsbuuPOyXI130_provenance.
• NP611459.RABkb7SPh7zM0VeINnLBr5x86KYSV9zwN-cPUKtwkjFI4130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP611459.RABkb7SPh7zM0VeINnLBr5x86KYSV9zwN-cPUKtwkjFI4130_provenance.
• NP368395.RAvA8I_tAhAMtzmzNMSkbmnMauUlmBVJXrA3qoIuEA2OQ130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368395.RAvA8I_tAhAMtzmzNMSkbmnMauUlmBVJXrA3qoIuEA2OQ130_provenance.
• NP402673.RAmHscnPWODWDyXzu-j9TDRfTE8Gce3ftgpkngUcKfVZM130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402673.RAmHscnPWODWDyXzu-j9TDRfTE8Gce3ftgpkngUcKfVZM130_provenance.
• NP402776.RAqU-SlVOqEMblM_ZQIVpW4K6LK31-36mKdwbMRUXkWsE130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402776.RAqU-SlVOqEMblM_ZQIVpW4K6LK31-36mKdwbMRUXkWsE130_provenance.
• NP403392.RAmERBI_sH_YUffxHm2d2ZR2mEOjKJKEqPK2-PXBQNgpM130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP403392.RAmERBI_sH_YUffxHm2d2ZR2mEOjKJKEqPK2-PXBQNgpM130_provenance.
• NP611582.RArIG1KrIWVLIR4_YzVe6aZL_U5fM3xBKBZ9qGJohawg0130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP611582.RArIG1KrIWVLIR4_YzVe6aZL_U5fM3xBKBZ9qGJohawg0130_provenance.
• NP584031.RAvd4yyQ1UDUraMzUUhdp8Qr2wGXtfVIye58idVFSzPXg130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584031.RAvd4yyQ1UDUraMzUUhdp8Qr2wGXtfVIye58idVFSzPXg130_provenance.
• NP584033.RAhuc0czxZXEUJ8pCZ23RJUxWuw3B2zUygM-NSvy1scO4130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584033.RAhuc0czxZXEUJ8pCZ23RJUxWuw3B2zUygM-NSvy1scO4130_provenance.
• NP584030.RAy2j_aKT2u0ZLgML0PPWwvpoOlCGlFFpz07H0cR1pbsA130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584030.RAy2j_aKT2u0ZLgML0PPWwvpoOlCGlFFpz07H0cR1pbsA130_provenance.
• NP584032.RA22QEIXFMbEg5PcpsMCbVTFnKCVKlEZXf7wB69_dwyF4130_assertion description "[Immunohistochemical staining for FHIT and PCNA proteins was carried out in 451 breast lesions showing nonproliferative benign breast disease (BBD) (n=263), proliferative BBD without atypia (n=128), proliferative BBD with atypia (n=11), carcinoma in situ (n=15) or invasive carcinoma (n=34) and for EGFR protein in a subset of 71 of these cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584032.RA22QEIXFMbEg5PcpsMCbVTFnKCVKlEZXf7wB69_dwyF4130_provenance.